Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Famciclovir Market by Type (125 mg Tablets, 250 mg Tablets, 500 mg Tablets), By Application (Cold Sores, Genital Herpes, Shingles) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Famciclovir Market by Type (125 mg Tablets, 250 mg Tablets, 500 mg Tablets), By Application (Cold Sores, Genital Herpes, Shingles) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 331250 4200 Pharma & Healthcare 377 124 Pages 4.7 (33)
                                          

Market Overview:


The global famciclovir market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of herpes virus infections, rising demand for oral antiviral drugs, and growing awareness about the benefits of famciclovir therapy. The global famciclovir market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 125 mg tablets, 250 mg tablets, and 500 mg tablets. On the basis of application, the market is divided into cold sores (herpes labialis), genital herpes (herpes simplex virus 2), and shingles (zoster). Geographically speaking, North America dominates this market followed by Europe due to better reimbursement scenario in these regions as compared to other regions such as Asia Pacific or Latin America.


Global Famciclovir Industry Outlook


Product Definition:


Famciclovir is a medication used to treat the herpes simplex virus (HSV) and varicella zoster virus (VZV). It is also used to prevent cytomegalovirus (CMV) disease in people with AIDS. Famciclovir is in a class of medications called antivirals. It works by stopping the growth of HSV and VZV.


125 mg Tablets:


125 mg Tablets is used for the treatment of recurrent infections due to CMV, HSV, and VZV. It is also used in the treatment of primary lyme disease when other treatments have failed. 125 mg Tablets are also used as an antiviral agent in patients suffering from HIV-1 infection and SARS-CoVs (Severe Acute Respiratory Syndrome).


250 mg Tablets:


250 mg Tablets is used for the treatment of recurrent infections due to CMV, HSV, and VZV. It is also used in the treatment of primary lyme disease when other treatments have failed. 250 mg Tablets are not recommended for children under the age of 12 as it has serious adverse effects on their developing bodies.


The global Famciclovir market size was valued at USD 692 million in 2018.


Application Insights:


In terms of application segmentation, the global famciclovir market is categorized into cold sores, genital herpes, shingles and others. The genital herpes segment held the largest share in 2017 owing to increasing awareness about early diagnosis and treatment of this disease. According to a survey conducted by the Centers for Disease Control and Prevention (CDC), it was estimated that around 1 out of 5 people aged 14 to 49 years have been diagnosed with Genital Herpes (GH). Moreover, an increase in incidence has been observed over the past few years which is expected to boost product demand during forecast period.


The shingles segment is expected register significant growth during forecast period due largely on high product penetration for its management along with other factors such as growing prevalence rate among older population group especially in countries like U.S.


Regional Analysis:


North America dominated the global market in 2017. The presence of a large number of manufacturers and suppliers coupled with high awareness levels regarding famciclovir usage is expected to drive the regional product demand over the forecast period. Moreover, increasing healthcare expenditure by governments along with rising investments by major pharmaceutical companies for developing novel drugs is also likely to contribute toward market growth over the next eight years.


Asia Pacific is anticipated to witness significant growth during the forecast period owing to an increase in disease prevalence rates especially in China and India.


Growth Factors:


  • Increasing incidence of herpes zoster
  • Growing demand for antiviral drugs in the treatment of herpes simplex virus infections
  • Rising awareness about the benefits of Famciclovir over other antiviral drugs
  • Technological advancements in the field of drug delivery systems that would improve patient compliance with therapy regimens
  • Availability of generic versions of Famciclovir

Scope Of The Report

Report Attributes

Report Details

Report Title

Famciclovir Market Research Report

By Type

125 mg Tablets, 250 mg Tablets, 500 mg Tablets

By Application

Cold Sores, Genital Herpes, Shingles

By Companies

Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals, Beijing Jialin Pharmaceutical, HETERO, Novartis, Shandong Luoxin Pharmaceutical Group, Chengdu Diao Pharmaceutical Group, HISUN

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

124

Number of Tables & Figures

87

Customization Available

Yes, the report can be customized as per your need.


Global Famciclovir Market Report Segments:

The global Famciclovir market is segmented on the basis of:

Types

125 mg Tablets, 250 mg Tablets, 500 mg Tablets

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Cold Sores, Genital Herpes, Shingles

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Novartis
  2. Mylan
  3. Teva
  4. Cipla
  5. Hikma
  6. Apotex
  7. Aurobindo Pharma
  8. Macleods Pharmaceuticals
  9. Beijing Jialin Pharmaceutical
  10. HETERO
  11. Novartis
  12. Shandong Luoxin Pharmaceutical Group
  13. Chengdu Diao Pharmaceutical Group
  14. HISUN

Global Famciclovir Market Overview


Highlights of The Famciclovir Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 125 mg Tablets
    2. 250 mg Tablets
    3. 500 mg Tablets
  1. By Application:

    1. Cold Sores
    2. Genital Herpes
    3. Shingles
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Famciclovir Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Famciclovir Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Famciclovir is an antiviral medication used to treat herpes simplex virus (HSV) infections. Famciclovir is also used to prevent HSV infections in people who are at high risk for them, such as those with HIV/AIDS or cancer.

Some of the key players operating in the famciclovir market are Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals, Beijing Jialin Pharmaceutical, HETERO, Novartis, Shandong Luoxin Pharmaceutical Group, Chengdu Diao Pharmaceutical Group, HISUN.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Famciclovir Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Famciclovir Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Famciclovir Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Famciclovir Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Famciclovir Market Size & Forecast, 2020-2028       4.5.1 Famciclovir Market Size and Y-o-Y Growth       4.5.2 Famciclovir Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 125 mg Tablets
      5.2.2 250 mg Tablets
      5.2.3 500 mg Tablets
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Cold Sores
      6.2.2 Genital Herpes
      6.2.3 Shingles
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Famciclovir Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Famciclovir Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 125 mg Tablets
      9.6.2 250 mg Tablets
      9.6.3 500 mg Tablets
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Cold Sores
      9.10.2 Genital Herpes
      9.10.3 Shingles
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 125 mg Tablets
      10.6.2 250 mg Tablets
      10.6.3 500 mg Tablets
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Cold Sores
      10.10.2 Genital Herpes
      10.10.3 Shingles
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 125 mg Tablets
      11.6.2 250 mg Tablets
      11.6.3 500 mg Tablets
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Cold Sores
      11.10.2 Genital Herpes
      11.10.3 Shingles
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 125 mg Tablets
      12.6.2 250 mg Tablets
      12.6.3 500 mg Tablets
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Cold Sores
      12.10.2 Genital Herpes
      12.10.3 Shingles
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 125 mg Tablets
      13.6.2 250 mg Tablets
      13.6.3 500 mg Tablets
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Cold Sores
      13.10.2 Genital Herpes
      13.10.3 Shingles
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Famciclovir Market: Competitive Dashboard
   14.2 Global Famciclovir Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Novartis
      14.3.2 Mylan
      14.3.3 Teva
      14.3.4 Cipla
      14.3.5 Hikma
      14.3.6 Apotex
      14.3.7 Aurobindo Pharma
      14.3.8 Macleods Pharmaceuticals
      14.3.9 Beijing Jialin Pharmaceutical
      14.3.10 HETERO
      14.3.11 Novartis
      14.3.12 Shandong Luoxin Pharmaceutical Group
      14.3.13 Chengdu Diao Pharmaceutical Group
      14.3.14 HISUN

Our Trusted Clients

Contact Us